289 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
royalties on net sales of PEDMARQSI in the licensed territories up to the mid-twenties. Norgine will be responsible for all commercialization activities
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
be subject to the applicable terms and conditions of this Agreement, (iii) Licensee shall remain responsible and liable for all of the sublicensee’s … will be responsible for the acts and omissions of its (and its Affiliate’s or sublicensee’s, as applicable) subcontractors in connection with their performance of any
UPLOAD
7mva31d9dl
28 Nov 23
Letter from SEC
12:00am
8-K/A
EX-99.1
1rrulcrhahxrt5
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
meoz8nr7j43dj7h kqi
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
ijl6qvxg7
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am